Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer

BACKGROUND: Cetuximab has been regularly added to the treatments for metastatic colorectal cancer worldwide. However, due to its therapeutic insensitivity and underlying mechanisms being largely unknown, the clinical implementation of cetuximab in colorectal cancer remains limited. METHODS: The gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chaoran, Hong, Hiju, Lu, Jiaoyang, Zhao, Xuan, Hu, Wenjun, Zhang, Sen, Zong, Yaping, Mao, Zhihai, Li, Jianwen, Wang, Mingliang, Feng, Bo, Sun, Jing, Zheng, Minhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196627/
https://www.ncbi.nlm.nih.gov/pubmed/30336768
http://dx.doi.org/10.1177/1533033818806905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196627/
https://www.ncbi.nlm.nih.gov/pubmed/30336768
http://dx.doi.org/10.1177/1533033818806905

Ejemplares similares